Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter,Investigator-blinded,Randomized, Comparative Study to Evaluate the Efficacy and Safety of Oral NXL103 Versus Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

NCT00949130 is registered in ClinicalTrials.gov with Novexel Inc as lead sponsor.

NCT NCT00949130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter,Investigator-blinded,Randomized, Comparative Study to Evaluate the Efficacy and Safety of Oral NXL103 Versus Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Lead sponsor
Novexel Inc
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
March 31, 2010
Enrollment
180 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial skin and skin structure infections